In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

G&W Laboratories Inc.

http://www.gwlabs.com

Latest From G&W Laboratories Inc.

Asia Deal Watch: Promethera Calls On Hao Tian For Asian JV To Advance Its Liver Candidates

Plus recent deals involving BeiGene, Assembly Biosciences, Piramal, Medivant, Revitope, Junshi, JW Therapeutics, Eureka, Acepodia, Chiesi, Bayer, NewG Lab, AnHeart

Deals M & A

Carlyle Pays Almost $500m For A Fifth Of Piramal Pharma

Private equity group Carlyle has acquired 20% of Piramal's pharma business for close to $500m, with the Indian group expected to use the capital raise to bolster organic and inorganic growth and deleverage the balance sheet.

Deals India

Carlyle's 20% Stake Gives Piramal Pharma 'War Chest' For Growth

Private equity group Carlyle has acquired 20% of Piramal’s pharma business for close to $500m, with the Indian group expected to use the capital raise to bolster organic and inorganic growth and deleverage the balance sheet.

Commercial Deals

Generic Industry Consolidating But Still Mysterious

Nearly 2,000 ANDAs remain unclaimed as US FDA begins fee calculations for GDUFA II.

Generic Drugs FDA
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register